Why Tsumura’s Daikenchuto keeps showing up in Japanese hospitals
Published on 06/22/2026 at 05:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Reviewed: ad hoc news Bestseller & Flagship desk. Edited and checked on 2026-06-22, 05:08. Details in the imprint.
With Tsumura Daikenchuto, a warm, slightly spicy cloud of ginger and ginseng aroma hits you the moment the sachet opens, yet this traditional granule is a standard prescription in many Japanese surgery wards. You stir the brown powder into hot water. The drink feels more like a sharp herbal tea than a bitter medicine.
Background on the Tsumura & Co stock
Tsumura’s focus on standardized Kampo formulas like Daikenchuto is central to its earnings story and to its strong footing in Japanese hospitals.
What Daikenchuto actually is
Daikenchuto is a granulated Kampo formula based on a classic combination of processed ginger, ginseng, Japanese pepper and malt sugar, standardized so every sachet delivers the same dosage. In Japanese prescribing practice it is often labeled as TJ-100, Tsumura’s internal code for the formula.
Patients usually receive Daikenchuto as small foil packets containing a few grams of brown granules, taken two or three times a day dissolved in warm water. The taste is unmistakable - hot ginger, a touch of peppery heat on the tongue, then a lingering sweet note from the malt sugar.
Where doctors use it in practice
In modern Japanese hospitals Daikenchuto is commonly prescribed after abdominal surgery, for example following colorectal or gastric operations, to help jump-start sluggish bowels and ease postoperative bloating. Surgeons describe it as a supportive measure alongside standard care, not as a replacement for conventional drugs.
Beyond surgery, gastroenterologists use the formula for chronic constipation, functional bowel disorders and sometimes in elderly patients whose digestion slows down with multiple medications. The goal is usually modest but tangible - less cramping, less painful gas, more regular movement without escalating to aggressive laxatives.
How it feels for the patient
On the ward the routine is almost ritualized. A nurse tears open the Daikenchuto sachet, tips the powder into a cup, adds hot water and stirs until the fine granules vanish. The aroma rises immediately - warm, woody, reminiscent of freshly sliced ginger in a kitchen.
Patients who dislike pills often find the drink easier to accept, though the peppery edge can surprise on the first sip. That gentle burn in the chest and stomach is exactly what many surgeons aim for - a sensation of warmth spreading through a belly that still feels frozen from anesthesia and surgical stress.
The science behind the warmth
Pharmacologically, researchers attribute Daikenchuto’s effects mainly to compounds in processed ginger and Japanese pepper that interact with TRP channels, receptors involved in sensing temperature and pain in the gut. The triggering of these receptors may promote intestinal motility and local blood flow, which in turn can ease postoperative ileus.
Clinical studies, many of them small and focused on Japanese patients, have reported shorter time to first flatus and earlier tolerance of food in surgery patients given Daikenchuto compared with control groups. The data are not unanimous, but the repeated positive signals explain why the formula has become part of standard Kampo-based protocols in numerous university hospitals.
Advantages in everyday hospital use
One quiet advantage for staff is predictability. Because Tsumura manufactures Daikenchuto under pharmaceutical good manufacturing practice, hospital pharmacists know that every packet of TJ-100 matches the approved formula and quality standards, batch after batch. There is no improvisation with loose herbs.
Administration is straightforward on busy wards. Granules dissolve quickly in warm water, and the instructions are simple enough that even groggy postoperative patients usually manage with light supervision. Compared with decoctions that need boiling, the sachet format saves time and avoids kitchen logistics.
Where Daikenchuto falls short
Still, Daikenchuto is not a miracle cure. Its benefits appear strongest in specific settings like postoperative ileus, while data for broader conditions such as irritable bowel syndrome remain more mixed and often limited to small, single-country trials. Western guidelines rarely mention it explicitly.
Side effects are typically mild - occasional heartburn, a feeling of excessive warmth, or loose stools - but those can matter in frail patients. There is also the cultural hurdle: outside Japan and a few neighboring markets, many doctors remain cautious about prescribing a multi-herb product they did not encounter in their training.
Availability and how patients get it
In Japan, Daikenchuto is a prescription Kampo medicine reimbursed under the national health insurance, sitting in the same electronic ordering systems as familiar Western drugs. Patients do not see a mystical remedy, but rather another line of text with a dosage and a Tsumura code.
In Europe, the situation is far patchier. While individual herbal blends inspired by Daikenchuto may be sold as supplements, the original Tsumura product is generally not distributed through regular pharmacies. Interested patients in Germany often encounter the formula only in specialist clinics with ties to Japanese Kampo training or via import channels.
What this means for Tsumura & Co
For Tsumura & Co, Daikenchuto is one of the formulas that anchor its position as the reference name for standardized Kampo in Japan. The company’s broader strategy revolves around keeping these traditional blends clinically relevant while expanding into new indications and, cautiously, overseas markets.
Simplifying, Daikenchuto shows how Tsumura tries to balance centuries-old herbal logic with hard hospital realities like reimbursement, stability data and physician trust. It is not the most glamorous product, but it is deeply embedded where daily prescribing decisions happen.
Stock angle in one sober line
Tsumura & Co (ISIN JP3429000008) is listed on the Tokyo Stock Exchange; Daikenchuto and other reimbursed Kampo formulas form a significant part of the company’s domestic prescription business, which in turn underpins its valuation on the Japanese market.
Key facts on Tsumura Daikenchuto
- Product: Tsumura Daikenchuto (TJ-100) granules
- Manufacturer: Tsumura & Co., Japan
- Category: Flagship/Bestseller Kampo prescription medicine
- Launch: Established Kampo formula, long-standing use in Japanese clinical practice
- RRP / Price: Reimbursed prescription product in Japan, patient co-pay depending on insurance rules
- Availability: Primarily Japanese hospitals and pharmacies, limited international access via specialist clinics or import
- Target group: Adults with postoperative ileus, chronic constipation or functional bowel symptoms under medical supervision
- Highlight / USP: Warm, ginger-forward Kampo granules standardized to pharmaceutical quality and embedded in routine Japanese hospital care
This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
